Concepedia

Luisa Chocarro

LC

Statistics

Publications

11

Citations

300

H-Index

11

Active since

2020

Affiliations

Navarrabiomed(Current)

Navarre Institute of Health Research

Universidad de Navarra

Complejo Hospitalario de Navarra

Universidad Pública de Navarra (UPNA)

Luisa Chocarro is an author at Navarrabiomed specializing in immunology, oncology, and cancer immunotherapy.

ORCID

Publications per year

2020–2024

11

Publications

11

Early Detection of Hyperprogressive Disease in Non-Small Cell Lung Cancer by Monitoring of Systemic T Cell Dynamics

Hugo Arasanz, Miren Zuazo, Ana Bocanegra et al. · Cancers · 2020 · 66 citations · Full text

, , +17

Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy

Marta Redondo-Muñoz, Francisco Javier Rodríguez‐Baena, Paula Aldaz et al. · Nature Metabolism · 2023 · 59 citations · Full text

, , +17

Circulating Low Density Neutrophils Are Associated with Resistance to First Line Anti-PD1/PDL1 Immunotherapy in Non-Small Cell Lung Cancer

Hugo Arasanz, Ana Bocanegra, Idoia Morilla et al. · Cancers · 2022 · 39 citations · Full text

, , +17

Systemic CD4 immunity: A powerful clinical biomarker for PD‐L1/PD‐1 immunotherapy

Miren Zuazo, Hugo Arasanz, Ana Bocanegra et al. · EMBO Molecular Medicine · 2020 · 31 citations · Full text

, , +17

The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity

Carolyn Edwards, Angelica Sette, Carl T. Cox et al. · British Journal of Cancer · 2021 · 17 citations · Full text

, , +17

1–5 of 11